Leveraging diverse algorithms from the Tumor Immune Estimation Resource (TIMER) database, we discovered an inverse relationship between NPC1L1 expression levels and the infiltration of CD8+ T cells in breast cancer tissues (Figure 6A). This evidence concerns the gene NPC1L1 and breast cancer.